These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16136394)

  • 21. Privilege revisited: an evaluation of the eye's defence mechanisms.
    Forrester JV
    Eye (Lond); 2009 Apr; 23(4):756-66. PubMed ID: 18989350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic control of complement activation in humans and age related macular degeneration.
    Hecker LA; Edwards AO
    Adv Exp Med Biol; 2010; 703():49-62. PubMed ID: 20711706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IBI302, a promising candidate for AMD treatment, targeting both the VEGF and complement system with high binding affinity in vitro and effective targeting of the ocular tissue in healthy rhesus monkeys.
    Ren X; Li J; Xu X; Wang C; Cheng Y
    Exp Eye Res; 2016 Apr; 145():352-358. PubMed ID: 26919788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The complement system contributes to the pathology of experimental autoimmune encephalomyelitis by triggering demyelination and modifying the antigen-specific T and B cell response.
    Hundgeburth LC; Wunsch M; Rovituso D; Recks MS; Addicks K; Lehmann PV; Kuerten S
    Clin Immunol; 2013 Mar; 146(3):155-64. PubMed ID: 23352967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complement involvement in neovascular ocular diseases.
    Yanai R; Thanos A; Connor KM
    Adv Exp Med Biol; 2012; 946():161-83. PubMed ID: 21948368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complement activation as a biomarker for Alzheimer's disease.
    Aiyaz M; Lupton MK; Proitsi P; Powell JF; Lovestone S
    Immunobiology; 2012 Feb; 217(2):204-15. PubMed ID: 21856034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Age-related macular degeneration: Complement in action.
    van Lookeren Campagne M; Strauss EC; Yaspan BL
    Immunobiology; 2016 Jun; 221(6):733-9. PubMed ID: 26742632
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disease-associated sequence variations in factor H: a structural biology approach.
    Herbert AP; Soares DC; Pangburn MK; Barlow PN
    Adv Exp Med Biol; 2006; 586():313-27. PubMed ID: 16893081
    [No Abstract]   [Full Text] [Related]  

  • 29. A computational model for the evaluation of complement system regulation under homeostasis, disease, and drug intervention.
    Zewde N; Morikis D
    PLoS One; 2018; 13(6):e0198644. PubMed ID: 29874282
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inherited complement regulatory protein deficiency predisposes to human disease in acute injury and chronic inflammatory statesthe examples of vascular damage in atypical hemolytic uremic syndrome and debris accumulation in age-related macular degeneration.
    Richards A; Kavanagh D; Atkinson JP
    Adv Immunol; 2007; 96():141-77. PubMed ID: 17981206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The complement system in age-related macular degeneration: A review of rare genetic variants and implications for personalized treatment.
    Geerlings MJ; de Jong EK; den Hollander AI
    Mol Immunol; 2017 Apr; 84():65-76. PubMed ID: 27939104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of complement in the induction and regulation of immune responses.
    Egwang TG; Befus AD
    Immunology; 1984 Feb; 51(2):207-24. PubMed ID: 6363279
    [No Abstract]   [Full Text] [Related]  

  • 33. Impact of inflammation on ocular immune privilege.
    Mo JS; Wang W; Kaplan HJ
    Chem Immunol Allergy; 2007; 92():155-165. PubMed ID: 17264491
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The complement system in ocular allergy.
    Mondino BJ; Phinney R
    Int Ophthalmol Clin; 1988; 28(4):329-31. PubMed ID: 3053494
    [No Abstract]   [Full Text] [Related]  

  • 35. The complement system facilitates clearance of Enterococcus faecium during murine peritonitis.
    Leendertse M; Willems RJ; Flierman R; de Vos AF; Bonten MJ; van der Poll T
    J Infect Dis; 2010 Feb; 201(4):544-52. PubMed ID: 20064073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complement system and the eye.
    Jha P; Bora PS; Sohn JH; Kaplan HJ; Bora NS
    Adv Exp Med Biol; 2006; 586():53-62. PubMed ID: 16893064
    [No Abstract]   [Full Text] [Related]  

  • 37. Complement regulators in human disease: lessons from modern genetics.
    Liszewski MK; Atkinson JP
    J Intern Med; 2015 Mar; 277(3):294-305. PubMed ID: 25495259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complement depletion with humanized cobra venom factor in a mouse model of age-related macular degeneration.
    Fritzinger DC; Dean R; Meschter C; Wong K; Halter R; Borlak J; St John WD; Vogel CW
    Adv Exp Med Biol; 2010; 703():151-62. PubMed ID: 20711713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complement activation and choriocapillaris loss in early AMD: implications for pathophysiology and therapy.
    Whitmore SS; Sohn EH; Chirco KR; Drack AV; Stone EM; Tucker BA; Mullins RF
    Prog Retin Eye Res; 2015 Mar; 45():1-29. PubMed ID: 25486088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune Privilege and Eye-Derived T-Regulatory Cells.
    Keino H; Horie S; Sugita S
    J Immunol Res; 2018; 2018():1679197. PubMed ID: 29888291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.